IL222277A0 - Pharmaceutical compositions highly dosed with biotin - Google Patents
Pharmaceutical compositions highly dosed with biotinInfo
- Publication number
- IL222277A0 IL222277A0 IL222277A IL22227712A IL222277A0 IL 222277 A0 IL222277 A0 IL 222277A0 IL 222277 A IL222277 A IL 222277A IL 22227712 A IL22227712 A IL 22227712A IL 222277 A0 IL222277 A0 IL 222277A0
- Authority
- IL
- Israel
- Prior art keywords
- biotin
- pharmaceutical compositions
- compositions highly
- highly dosed
- dosed
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Ophthalmology & Optometry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1052589A FR2958166B1 (en) | 2010-04-06 | 2010-04-06 | PHARMACEUTICAL COMPOSITIONS HIGHLY DOSE IN BIOTIN |
PCT/EP2011/055273 WO2011124571A1 (en) | 2010-04-06 | 2011-04-05 | Pharmaceutical compositions highly dosed with biotin |
Publications (2)
Publication Number | Publication Date |
---|---|
IL222277A0 true IL222277A0 (en) | 2012-12-31 |
IL222277B IL222277B (en) | 2018-06-28 |
Family
ID=42651240
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL222277A IL222277B (en) | 2010-04-06 | 2012-10-09 | Pharmaceutical compositions highly dosed with biotin |
Country Status (17)
Country | Link |
---|---|
US (1) | US20130084334A1 (en) |
EP (1) | EP2555771B1 (en) |
CA (1) | CA2795465C (en) |
CY (1) | CY1118967T1 (en) |
DK (1) | DK2555771T3 (en) |
ES (1) | ES2613977T3 (en) |
FR (1) | FR2958166B1 (en) |
HR (1) | HRP20170172T1 (en) |
HU (1) | HUE031767T2 (en) |
IL (1) | IL222277B (en) |
LT (1) | LT2555771T (en) |
PL (1) | PL2555771T3 (en) |
PT (1) | PT2555771T (en) |
RS (1) | RS55696B1 (en) |
SI (1) | SI2555771T1 (en) |
SM (1) | SMT201700122B (en) |
WO (1) | WO2011124571A1 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2993780B1 (en) * | 2012-07-26 | 2015-02-13 | Assist Publ Hopitaux De Paris | METHOD OF TREATING PLATE SCLEROSIS |
WO2014177286A1 (en) | 2013-04-29 | 2014-11-06 | Assistance Publique - Hopitaux De Paris | Biotin for use in treating x-linked adrenoleukodystrophy |
EP3072513A1 (en) | 2015-03-26 | 2016-09-28 | Medday | Biotin for treating Amyotrophic lateral sclerosis |
EP3275439A1 (en) | 2016-07-29 | 2018-01-31 | Medday Pharmaceuticals | Method for treating hepatic encephalopathy |
CN113827591B (en) * | 2021-11-09 | 2023-06-09 | 上海市肺科医院 | Application of biotin in preparation of medicines for treating sepsis |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0995448A (en) * | 1995-09-29 | 1997-04-08 | Calpis Food Ind Co Ltd:The | Increase in biotin concentration in blood and biotin-containing beverage or food product |
US5789401A (en) * | 1997-08-08 | 1998-08-04 | Nutrition 21 | High-dose chromium/biotin treatment of type II diabetes |
JP2005536543A (en) * | 2002-08-23 | 2005-12-02 | ディーエスエム アイピー アセッツ ビー.ブイ. | Novel dietary supplement composition containing biotin |
WO2004028523A1 (en) * | 2002-09-30 | 2004-04-08 | Daiichi Pharmaceutical Co., Ltd. | Particulate product comprising pantethine |
IL162288A0 (en) * | 2004-06-01 | 2005-11-20 | Future Products Man S A | Compositions and methods for treating neurodegenerative disorders |
US8609165B1 (en) * | 2009-07-02 | 2013-12-17 | E5 Llc | Dietary supplement for optimizing glucose levels, increasing energy, and improving general health |
FR2993780B1 (en) * | 2012-07-26 | 2015-02-13 | Assist Publ Hopitaux De Paris | METHOD OF TREATING PLATE SCLEROSIS |
-
2010
- 2010-04-06 FR FR1052589A patent/FR2958166B1/en not_active Expired - Fee Related
-
2011
- 2011-04-05 PT PT117142521T patent/PT2555771T/en unknown
- 2011-04-05 PL PL11714252T patent/PL2555771T3/en unknown
- 2011-04-05 SI SI201131092A patent/SI2555771T1/en unknown
- 2011-04-05 RS RS20170135A patent/RS55696B1/en unknown
- 2011-04-05 EP EP11714252.1A patent/EP2555771B1/en active Active
- 2011-04-05 CA CA2795465A patent/CA2795465C/en not_active Expired - Fee Related
- 2011-04-05 ES ES11714252.1T patent/ES2613977T3/en active Active
- 2011-04-05 WO PCT/EP2011/055273 patent/WO2011124571A1/en active Application Filing
- 2011-04-05 HU HUE11714252A patent/HUE031767T2/en unknown
- 2011-04-05 LT LTEP11714252.1T patent/LT2555771T/en unknown
- 2011-04-05 DK DK11714252.1T patent/DK2555771T3/en active
- 2011-04-05 US US13/639,752 patent/US20130084334A1/en not_active Abandoned
-
2012
- 2012-10-09 IL IL222277A patent/IL222277B/en active IP Right Grant
-
2017
- 2017-02-02 HR HRP20170172TT patent/HRP20170172T1/en unknown
- 2017-02-22 SM SM201700122T patent/SMT201700122B/en unknown
- 2017-02-22 CY CY20171100241T patent/CY1118967T1/en unknown
Also Published As
Publication number | Publication date |
---|---|
FR2958166A1 (en) | 2011-10-07 |
DK2555771T3 (en) | 2017-02-13 |
PT2555771T (en) | 2017-01-17 |
WO2011124571A1 (en) | 2011-10-13 |
CY1118967T1 (en) | 2018-01-10 |
HRP20170172T1 (en) | 2017-04-07 |
US20130084334A1 (en) | 2013-04-04 |
SMT201700122B (en) | 2017-03-08 |
RS55696B1 (en) | 2017-07-31 |
LT2555771T (en) | 2017-04-10 |
CA2795465C (en) | 2018-10-30 |
EP2555771B1 (en) | 2016-11-23 |
IL222277B (en) | 2018-06-28 |
CA2795465A1 (en) | 2011-10-13 |
SI2555771T1 (en) | 2017-03-31 |
ES2613977T3 (en) | 2017-05-29 |
EP2555771A1 (en) | 2013-02-13 |
PL2555771T3 (en) | 2017-07-31 |
FR2958166B1 (en) | 2012-07-13 |
HUE031767T2 (en) | 2017-07-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1246170A1 (en) | Pharmaceutical composition | |
ZA201300458B (en) | C-met-modulator pharmaceutical compositions | |
ZA201301766B (en) | Pharmaceutical compositions | |
IL225457A0 (en) | Pharmaceutical composition | |
LT2619182T (en) | Pharmaceutical composition | |
ZA201300718B (en) | Pharmaceutical compositions | |
ZA201207670B (en) | Pharmaceutical compositions | |
PT2579858E (en) | Ivabradine-containing pharmaceutical composition | |
ZA201301920B (en) | Pharmaceutical composition | |
ZA201303223B (en) | Pharmaceutical compositions | |
GB201010453D0 (en) | Pharmaceutical composition | |
IL222277A0 (en) | Pharmaceutical compositions highly dosed with biotin | |
ZA201303177B (en) | Pharmaceutical compositions | |
GB201001911D0 (en) | Pharmaceutical composition | |
EP2560678A4 (en) | Pharmaceutical compositions | |
ZA201303732B (en) | Pharmaceutical compositions | |
GB201008590D0 (en) | Pharmaceutical compositions | |
GB201019775D0 (en) | Pharmaceutical composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
KB20 | Patent renewed for 20 years |